These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2754552)

  • 21. Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation.
    Lloyd-Still JD; Johnson SB; Holman RT
    Am J Clin Nutr; 1981 Jan; 34(1):1-7. PubMed ID: 7446449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NATURE OF RENAL ESCAPE FROM THE SODIUM-RETAINING EFFECT OF ALDOSTERONE IN PRIMARY ALDOSTERONISM AND IN NORMAL SUBJECTS.
    ROVNER DR; CONN JW; KNOPF RF; COHEN EL; HSUEH MT
    J Clin Endocrinol Metab; 1965 Jan; 25():53-64. PubMed ID: 14252288
    [No Abstract]   [Full Text] [Related]  

  • 23. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
    Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal haemodynamic changes, renal tubular function, sodium and water homeostatic hormones in patients with chronic glomerulonephritis and in healthy humans after intravenous infusion of amino acids.
    Tietze IN; Pedersen EB
    Nephrol Dial Transplant; 1994; 9(5):499-504. PubMed ID: 8090330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study.
    Levy J; Smith AL; Koup JR; Williams-Warren J; Ramsey B
    J Pediatr; 1984 Jul; 105(1):117-24. PubMed ID: 6376743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.
    Maack T; Marion DN; Camargo MJ; Kleinert HD; Laragh JH; Vaughan ED; Atlas SA
    Am J Med; 1984 Dec; 77(6):1069-75. PubMed ID: 6239544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal function, sodium and water homeostasis in patients with idiopathic extrahepatic portal vein thrombosis compared with normal healthy controls.
    Rayner BL; Robson SC; Kirsch RE; Voigt M
    S Afr Med J; 2001 Jan; 91(1):61-5. PubMed ID: 11236301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Essential fatty acid status and fluidity of plasma phospholipids in cystic fibrosis infants.
    Lloyd-Still JD; Johnson SB; Holman RT
    Am J Clin Nutr; 1991 Dec; 54(6):1029-35. PubMed ID: 1957818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis.
    De Vizia B; Raia V; Spano C; Pavlidis C; Coruzzo A; Alessio M
    JPEN J Parenter Enteral Nutr; 2003; 27(1):52-7. PubMed ID: 12549599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Glomerular function and urine acidification in chronic renal diseases].
    Mizukami K
    Nihon Jinzo Gakkai Shi; 1990 Jan; 32(1):1-11. PubMed ID: 2161472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of glomerular filtration rate and effective renal plasma flow in cystic fibrosis.
    Spino M; Chai RP; Isles AF; Balfe JW; Brown RG; Thiessen JJ; MacLeod SM
    J Pediatr; 1985 Jul; 107(1):64-70. PubMed ID: 3891948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty acid supplementation in cystic fibrosis.
    Berg U; Kallner A; Kusoffsky E; Strandvik B
    Monogr Paediatr; 1979; 10():1-4. PubMed ID: 460262
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine natriuresis in salt-repleted, water-loaded humans: a dose-response study.
    Olsen NV; Olsen MH; Bonde J; Kanstrup IL; Plum I; Strandgaard S; Leyssac PP
    Br J Clin Pharmacol; 1997 May; 43(5):509-20. PubMed ID: 9159566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective study of fatty acid supplementation over 3 years in patients with cystic fibrosis.
    Kusoffsky E; Strandvik B; Troell S
    J Pediatr Gastroenterol Nutr; 1983; 2(3):434-8. PubMed ID: 6413667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis.
    Hedman A; Alván G; Strandvik B; Arvidsson A
    Clin Pharmacokinet; 1990 Feb; 18(2):168-75. PubMed ID: 2180614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects.
    Henderson WR; Astley SJ; McCready MM; Kushmerick P; Casey S; Becker JW; Ramsey BW
    J Pediatr; 1994 Mar; 124(3):400-8. PubMed ID: 8120709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis.
    Strandvik B; Gronowitz E; Enlund F; Martinsson T; Wahlström J
    J Pediatr; 2001 Nov; 139(5):650-5. PubMed ID: 11713441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tubular excretion of benzylpenicillin in patients with cystic fibrosis.
    Bins JW; Mattie H
    Br J Clin Pharmacol; 1989 Mar; 27(3):291-4. PubMed ID: 2719893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.